Literature DB >> 17653652

Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities.

Keiichi Fujiwara1, Osamu Yokosuka, Fumio Imazeki, Makoto Miki, Kazuyuki Suzuki, Kiwamu Okita, Eiji Tanaka, Masao Omata.   

Abstract

BACKGROUND: In our recent study of the full-length hepatitis A virus (HAV) genome from some patients with fulminant hepatitis and acute hepatitis, possible associations were suggested between the severity of hepatitis A and the amino acid substitutions in the nonstructural protein 2B. We therefore analyzed HAV 2B from many patients with various clinical disease severities.
METHODS: Serum samples from 30 Japanese patients with sporadic hepatitis A from five widely separated regions of Japan, comprising nine patients with fulminant hepatitis (FH), six with severe acute hepatitis (AHs), and 15 with acute hepatitis (AH), were examined for HAV RNA. The entire sequences of HAV 2B were analyzed.
RESULTS: Compared with the sequence of the wild-type HAV strain GBM, nucleotide sequences of 2B had homology of 94.5 +/- 1.0% in FH, 95.2 +/- 1.2% in AHs, and 95.1 +/- 1.8% in AH. Deduced amino acid sequences had homology of 97.5 +/- 2.1% in FH, 97.9 +/- 2.4% in AHs, and 98.5 +/- 1.3% in AH. Differences were not statistically significant among the three groups. The average number of amino acid mutations between amino acids 100 and 200 was 5.0 +/- 5.2 per case in FH, 4.0 +/- 6.0 in AHs, and 1.9 +/- 2.9 in AH. The differences between FH and AH, AHs and AH, and between severe cases (FH and AHs) and nonsevere cases (AH) were not statistically significant (P = 0.13, P = 0.45, and P = 0.10, respectively).
CONCLUSIONS: There were no obvious differences in the sequences among FH, AHs, and AH throughout the 2B region, but there seemed to be more mutations in the strains obtained from FH and AHs patients than in those obtained from AH patients in the central part of HAV 2B.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653652     DOI: 10.1007/s00535-007-2039-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  25 in total

1.  Mutations in both the 2B and 2C genes of hepatitis A virus are involved in adaptation to growth in cell culture.

Authors:  S U Emerson; Y K Huang; C McRill; M Lewis; R H Purcell
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  A cytopathogenic, apoptosis-inducing variant of hepatitis A virus.

Authors:  K Brack; W Frings; A Dotzauer; A Vallbracht
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

3.  An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect.

Authors:  H Zhang; S F Chao; L H Ping; K Grace; B Clarke; S M Lemon
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

4.  PCR-SSCP analysis of 5'-nontranslated region of hepatitis A viral RNA: comparison with clinicopathological features of hepatitis A.

Authors:  K Fujiwara; O Yokosuka; T Ehata; F Imazeki; H Saisho
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

5.  Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis.

Authors:  K Fujiwara; O Yokosuka; K Fukai; F Imazeki; H Saisho; M Omata
Journal:  J Hepatol       Date:  2001-07       Impact factor: 25.083

6.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

Authors:  S Vento; T Garofano; C Renzini; F Cainelli; F Casali; G Ghironzi; T Ferraro; E Concia
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

7.  Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A.

Authors:  K Fujiwara; O Yokosuka; T Ehata; F Imazeki; H Saisho; M Miki; M Omata
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

8.  Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation.

Authors:  J Graff; C Kasang; A Normann; M Pfisterer-Hunt; S M Feinstone; B Flehmig
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

9.  Genetic analysis of hepatitis A virus protein 2C in sera from patients with fulminant and self-limited hepatitis A.

Authors:  Keiichi Fujiwara; Osamu Yokosuka; Fumio Imazeki; Makoto Miki; Kazuyuki Suzuki; Kiwamu Okita; Eiji Tanaka; Masao Omat
Journal:  Hepatogastroenterology       Date:  2007 Apr-May

10.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  1 in total

1.  A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans.

Authors:  Hye Young Kim; María Belén Eyheramonho; Muriel Pichavant; Carlos Gonzalez Cambaceres; Ponpan Matangkasombut; Guillermo Cervio; Silvina Kuperman; Rita Moreiro; Krishnamurthy Konduru; Mohanraj Manangeeswaran; Gordon J Freeman; Gerardo G Kaplan; Rosemarie H DeKruyff; Dale T Umetsu; Sergio D Rosenzweig
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.